MATERIALS AND METHODS
µL of SnCl4 was added and the reaction allowed to proceed for 24
h. The reaction mixture was poured into cold H2O (20 mL) and
diluted with CHCl3 (5 mL). The organic layer was separated, and
the aqueous phase was concentrated under reduced pressure,
purified by silica gel chromatography (eluent system: MeOH in
CHCl3 from 20% to 30%), and passed through a DOWEX H+ ion-
All reagents were of the highest commercially available quality
and were used as received. L-Arabinose was purchased from
Sigma. NMR spectra were recorded on Bruker WM-400, Varian
Gemini 300, Varian Gemini 200, and Varian Inova 500 spectrom-
eters. All chemical shifts are expressed in parts per million with
respect to the residual solvent signal. For electrospray ionization
spectroscopy mass spectrometry (ESI-MS) analyses, a Waters
Micromass ZQ instrument, equipped with an electrospray source,
was used in the positive and/or negative mode. 1-[3-(Dimethy-
lamino)propyl]-3-ethylcarbodiimide (EDC), bovine serum albumin
(BSA; fraction V), and ovalbumin (OVA; grade V) were purchased
from Sigma. PURE1A Protein A Antibody Purification Kit was
purchased from Sigma. Goat polyclonal to rabbit IgG-HRP
conjugate (secondary antibody) was from Abcam. Affinity resin
EAH Sepharose 4B was purchased from Amersham Biosciences.
Nitrocellulose transfer membrane Protran from Schleicher &
Schuell and ECL detection reagents from Amersham Biosciences
were used in dot blot and Western blot experiments. Microplates
(96-well), LockWell MaxiSorp from Nunc, 3,3′,5,5′-tetramethyl-
benzidine (TMB) enzyme substrate from Sigma, and a microplate
reader, Multiskan EX from Thermo, were used for ELISA
experiments. UV measurements (detection at λ ) 278 nm) were
carried out on a Varian Cary 50 Bio spectrophotometer. Tetram-
ethylrhodamine isothiocyanate (TMRI) was purchased from
Sigma. Fluorescence experiments were carried out on an ISS K2
fluorometer (ISS, Champaign, IL).
Synthesis and Characterization of Patulin Derivatives.
Synthesis of 4-{[4-(Benzyloxy)-2-oxo-2,6,7,7a-tetrahydro-4H-furo[3,2-
c]pyran-7-yl]oxy}-4-oxobutanoic Acid (3). 4-(Benzyloxy)-7-hydroxy-
7,7a-dihydro-4H-furo[3,2-c]pyran-2(6H)-one (2; 350 mg, 1.37 mmol)
was dissolved in 9 mL of dry THF and treated with 16.7 mg of
DMAP (0.137 mmol) and 1.37 g of succinic anhydride (13.7
mmol), under stirring at room temperature. After 8 h, a second
aliquot of succinic anhydride (685 mg, 6.85 mmol) was added and
the reaction left for an additional 15 h. The reaction mixture was
concentrated under reduced pressure, then redissolved in 25 mL
of ethyl acetate, washed three times with water, and purified by
silica gel chromatography (eluent system: acetone in CHCl3, from
5% to 10%), which resulted in 330 mg (0.91 mmol, 68%) of 3 as a
pure compound. 1H NMR (400 MHz, CDCl3): δH 7.38-7.33 (5H,
complex signals, aromatic protons); 5.98 (1H, d, H-3); 5.70 (1H,
s, H-4); 5.48 (1H, d, H-7a); 5.23 (1H, m, H-7); 4.81 (1H, dd, J )
11.7 Hz, CHHPh); 4.65 (1H, dd, J ) 11.7 Hz, CHHPh); 4.05 (1H,
d, J ) 12.6 Hz, H-6); 3.90 (1H, dd, J ) 12.6 Hz, H-6′); 2.62 (4H, m,
H-10 and H-11). 13C NMR (100 MHz, CDCl3): δC 176.9 (C-9); 171.7
(C-2); 171.0 (C-12); 158.9 (C-3a); 136.1, 128.7, 128.4, and 128.1
(aromatic carbons); 115.0 (C-3); 93.3 (C-4); 77.6 (C-7a); 70.3 (C-
7); 69.7 (CH2Ph); 59.5 (C-6); 28.8 and 28.6 (C-10 and C-11). ESI-
MS m/z calcd for C18H18O8, 362.04; found (positive ions), 385.28
(M + Na+), 401.25 (M + K+).
1
exchange resin to obtain 75 mg (0.28 mmol, 67%) of pure 4. H
NMR (500 MHz, D2O): δH 6.25 (1H, s, H-3); 6.15 (1H, s, H-4);
5.62 (2H, overlapped signals, H-7 and H-7a); 4.36 (1H, d, J ) 13.5
Hz, H-6,); 3.96 (1H, dd, J ) 13.5 Hz and J ) 13.0 Hz, H-6′); 2.67
- 2.57 (4H, m, 4 × H of butanoic acid), 13C NMR (125 MHz,
D2O): δC 178.0 (C-4 of butanoic acid); 173.8 (C-1 of butanoic acid);
165.1 (C-2); 161.7 (C-3a); 114.5 (C-3); 89.0 (C-4); 77.1 (C-7a); 71.6
(C-7); 70.1 (C-6); 29.6 (C-2 and C-3 of butanoic acid). ESI-MS: m/z
calcd for C11H12O8, 272.05; found (positive ions), 255.15 (M - H2O
+ H+), 295.14 (M + Na+), 313.10 (M + K+).
Synthesis of 4-[(4-Hydroxy-2-oxohexahydro-4H-furo[3,2-c]pyran-
7-yl)oxy]-4-oxobutanoic Acid (5, P-sat-HS). To a solution of 3 (150
mg, 0.41 mmol) in 5 mL of MeOH was added a suspension of
150 mg of 10% Pd/C in MeOH (3 mL) under a flux of argon, and
the mixture was hydrogenated at atmospheric pressure for 16 h.
The reaction mixture was filtered through a Celite pad and
concentrated under reduced pressure. The residue was taken up
in 40 mL of H2O and washed twice with DCM. The aqueous layer
1
was concentrated to yield 90 mg (0.32 mmol, 80%) of pure 5. H
NMR (400 MHz, D2O): δH 5.32 (1H, m, H-7); 5.21 (1H, d, J ) 3.2
Hz, H-4); 5.10 (1H, m, H-7a); 4.16 (1H, dd, J ) 12.8 Hz and J )
2.4 Hz, H-6); 3.75 (1H, dd, J ) 13.2 Hz and J ) 1.6 Hz, H-6′); 2.80
- 2.60 (7H, overlapped signals, H-3; H-3a; 2CH2 of butanoic acid).
13C NMR (100 MHz, D2O): δC 183.9 (C-1 of butanoic acid); 183.1
(C-4 of butanoic acid); 177.2 (C-2); 95.9 (C-4); 77.9 (C-7a); 70.1
(C-7); 62.1 (C-3a); 42.7 (C-3); 34.7 (C-2 of butanoic acid); 33.1 (C-3
of butanoic acid). ESI-MS: m/z calcd for C11H14O8, 274.07; found
(positive ions), 297.15 (M + Na+), 313.12 (M + K+).
Synthesis of BSA Conjugates (Antigens A and B). Synthesis
of P-Ins-HS-BSA Conjugate (Antigen A). To a solution of P-Ins-
HS (2 mg, 0.0073 mmol) in 0.5 mL of MES buffer (0.1 M), pH 5,
were added 0.2 mL of a solution of BSA (4 mg‚mL-1) in the same
buffer and 0.1 mL of an EDC solution in H2O (10 mg‚mL-1). The
reaction mixture was incubated for 2 h at room temperature and
then dialyzed against 0.5 L of PBS (0.01 M), NaCl (0.01 M), pH
7.4 (0.5 L, for 3 days with daily buffer changes). The concentration
of the conjugate, spectrophotometrically determined at λ ) 278
nm, was 2.8 mg‚mL-1
.
Synthesis of P-Sat-HS-BSA Conjugate (Antigen B). To a solution
of P-Sat-HS (1.5 mg, 0.0054 mmol) in Tris (pH 8)/dioxane, 1:1
(v/v, 0.4 mL), were added 20 µL (1.0 mg, 0.0054 mmol) of an
EDC solution in H2O (50 mg‚mL-1) and 0.5 mL of a BSA solution
(8 mg‚mL-1) in PBS (0.1 M) at pH 7.4. After 2 h at room
temperature, the reaction mixture was dialyzed against PBS (0.01
M), NaCl (0.01 M), pH 7.4 (0.5 L, for 3 days with daily buffer
changes). The conjugate concentration determined spectropho-
Synthesis of 4-[(4-Hydroxy-2-oxo-2,6,7,7a-tetrahydro-4H-furo[3,2-
c]pyran-7-yl)oxy]-4-oxobutanoic Acid (4, P-ins-HS). To a solution
of 3 (150 mg, 0.41 mmol) in dry DCM (10 mL) was slowly added
SnCl4 (150 µL) at room temperature. After 24 h an additional 75
tometrically at λ ) 278 nm was 4.2 mg‚mL-1
.
Antibody Production and Purification. Antibody Production.
Two rabbits were immunized following a standard protocol by
intradermal inoculation of a mixture of antigens A and B (0.5 mg
each per rabbit). After the immunization period, the rabbits were
(33) Warden, B. A.; Allam, K.; Sentissi, A.; Cecchini, D. J.; Giese, R. W. Anal.
Biochem. 1987, 162, 363-369.
(34) Green, T. M.; Charles, P. T.; Anderson, G. P. Anal. Biochem. 2002, 310,
36-41.
Analytical Chemistry, Vol. 79, No. 2, January 15, 2007 753